[

who

]

Awaiting more information on Covaxin: WHO

  • The WHO’s nod for Covaxin’s emergency use authorisation is necessary for its widespread acceptability as a safe and effective vaccine.
The UN health agency said it is expecting one additional piece of information from Covaxin manufacturer, Bharat Biotech, which has been submitting data to the WHO on a rolling basis.
The UN health agency said it is expecting one additional piece of information from Covaxin manufacturer, Bharat Biotech, which has been submitting data to the WHO on a rolling basis.
Published on Oct 19, 2021 12:27 AM IST
Copy Link
By HT Correspondent, Hindustan Times, New Delhi

WHO forms 'last chance' to find Covid-19 origins, urges China to provide data

Despite first human cases of Covid-19 reported in Wuhan, China has repeatedly dismissed theories. A WHO-led team spent four weeks in and around Wuhan earlier this year, insisting that the virus had probably been transmitted from bats to humans through another animal but further research was needed.
Security personnel keep watch outside Wuhan Institute of Virology during the visit by the World Health Organization (WHO) team tasked with investigating the origins of the coronavirus disease (Covid-19), in Wuhan, Hubei province, China(REUTERS/Thomas Peter/File Photo)
Security personnel keep watch outside Wuhan Institute of Virology during the visit by the World Health Organization (WHO) team tasked with investigating the origins of the coronavirus disease (Covid-19), in Wuhan, Hubei province, China(REUTERS/Thomas Peter/File Photo)
Updated on Oct 14, 2021 08:04 AM IST
Copy Link
Reuters | | Posted by Zarafshan Shiraz, Geneva

‘Next 6-8 weeks are important as…’: Guleria on how Covid cases can drop

AIIMS director Dr Randeep Guleria said that he is hopeful Covaxin will soon be able to receive the WHO nod and travelling overseas will become easier for those who have taken both shots of the coronavirus vaccine.
AIIMS director Dr Randeep Guleria said that he is “hopeful” the approval of Covaxin by the WHO should happen soon. (ANI Photo)
AIIMS director Dr Randeep Guleria said that he is “hopeful” the approval of Covaxin by the WHO should happen soon. (ANI Photo)
Updated on Oct 01, 2021 06:26 PM IST
Copy Link
Written by Sharangee Dutta | Edited by Poulomi Ghosh, Hindustan Times, New Delhi

Working with WHO to get emergency use listing for Covaxin: Bharat Biotech

  • The company was responding to reports that said the grant of EUL could be delayed further as WHO had more technical queries regarding the inactivated whole virus vaccine.
Bharat Biotech is working with the World Health Organization (WHO) to obtain Emergency Use Listing for Covaxin, its Covid vaccine. (PTI)
Bharat Biotech is working with the World Health Organization (WHO) to obtain Emergency Use Listing for Covaxin, its Covid vaccine. (PTI)
Updated on Sep 29, 2021 03:13 AM IST
Copy Link
By Rhythma Kaul, New Delhi

Delta globally dominant variant, replacing other variants of concern: WHO

  • The WHO has downgraded alpha, beta, gamma along with three other variants - eta, iota and kappa, as they are being outcompeted by delta.
The delta variant has been detected in 185 countries till date. (Satish Bate / HT Photo)
The delta variant has been detected in 185 countries till date. (Satish Bate / HT Photo)
Published on Sep 23, 2021 08:30 AM IST
Copy Link
By hindustantimes.com | Written by Ayshee Bhaduri | Edited by Amit Chaturvedi, Hindustan Time, New Delhi

WHO thanks India as Modi govt announces resumption of Covid vaccine export

Why WHO thanked India's health minister
Why WHO thanked India's health minister
Published on Sep 22, 2021 02:25 PM IST
Copy Link

WHO chief thanks Mansukh Mandaviya for resuming vaccine exports to COVAX pool

  • Sharing a tweet, the WHO chief wrote, “Thank you Health Minister Mansukh Mandaviya for announcing India will resume crucial Covid vaccine shipments to COVAX in October.”
Calling it an “important development”, the WHO chief further said India’s contribution will help all COVAX-supported countries reach the 40 per cent vaccination target rate by the end of the year.(REUTERS)
Calling it an “important development”, the WHO chief further said India’s contribution will help all COVAX-supported countries reach the 40 per cent vaccination target rate by the end of the year.(REUTERS)
Published on Sep 22, 2021 10:56 AM IST
Copy Link
By hindustantimes.com | Written by Ayshee Bhaduri | Edited by Sohini Goswami, Hindustan Times, New Delhi

Bill Gates, WHO praise India for 1 crore vaccinations in a day | Covid

Bill Gates, WHO's Soumya Swaminathan congratulated India on crossing 1-crore daily vaccination mark (Agencies)
Bill Gates, WHO's Soumya Swaminathan congratulated India on crossing 1-crore daily vaccination mark (Agencies)
Published on Aug 28, 2021 01:46 PM IST
Copy Link

Covid in children mostly mild, but good to be prepared: WHO's Soumya Swaminathan

  • The effect of the coronavirus disease among children had been mostly mild and the severity much less than that in the adult population, said World Health Organization (WHO) chief scientist Dr Soumya Swaminthan, even as she stressed the importance of having a well-developed paediatric infrastructure.
“We should not panic about thousands of children crowding into ICUs
“We should not panic about thousands of children crowding into ICUs" said World Health Organization (WHO) chief scientist Soumya Swaminathan(REUTERS / File Photo)
Published on Aug 25, 2021 02:33 PM IST
Copy Link
By hindustantimes.com | Written by Ayshee Bhaduri | Edited by Sohini Goswami, Hindustan Times, New Delhi

Kabul airport curbs blocking medical, food supplies to Afghanistan: WHO

  • The WHO said the closure of the Hamid Karzai International Airport to commercial flights has held up deliveries to nearly 18.5 million people of Afghanistan, who rely on aid and humanitarian needs.
The executive director of the UN children's agency UNICEF, Henrietta Fore, said on Monday around 10 million children across Afghanistan need humanitarian assistance.
The executive director of the UN children's agency UNICEF, Henrietta Fore, said on Monday around 10 million children across Afghanistan need humanitarian assistance.
Published on Aug 23, 2021 11:00 PM IST
Copy Link
Reuters | | Posted by Sharangee Dutta, Hindustan Times, New Delhi

China rejects need for further WHO coronavirus origins probe

  • On Thursday the WHO urged China to share raw data from the earliest Covid-19 cases to revive its probe into the origins of the disease.
Police officers wearing protective gear against the spread of Covid-19 spray disinfectant at Nanjing port in China's eastern Jiangsu province.(AFP)
Police officers wearing protective gear against the spread of Covid-19 spray disinfectant at Nanjing port in China's eastern Jiangsu province.(AFP)
Updated on Aug 13, 2021 11:17 AM IST
Copy Link
AFP |

Prioritise school reopening with adherence to Covid norms: WHO scientist

  • WHO scientist also noted that the impact of the pandemic will last a long time on children's mental, physical and cognitive well-being.
Students to visit schools for admission and board examination related activities.(File Photo)
Students to visit schools for admission and board examination related activities.(File Photo)
Published on Aug 11, 2021 02:28 PM IST
Copy Link
By hindustantimes.com, New Deli

'Let's be careful for 6 months': WHO chief scientist on India Covid situation

Children are not at greater risk, Dr Swaminathan said, citing ICMR data which shows that children have been exposed to the virus in the previous waves.
The six month period is not for the virus to disappear, but for vaccine coverage to increase, Dr Soumya Swaminathan has explained.
The six month period is not for the virus to disappear, but for vaccine coverage to increase, Dr Soumya Swaminathan has explained.
Published on Aug 06, 2021 08:02 PM IST
Copy Link
By hindustantimes.com | Written by Poulomi Ghosh

WHO calls for moratorium on booster shots

  • The halt on third doses should be in place until at least the end of September, director-general Tedros Adhanom Ghebreyesus said at a media briefing on Wednesday.
Adhanom Ghebreyesus also called on vaccine producers to prioritise Covax, the programme set up last year to equitably distribute vaccines to every corner of the planet. REUTERS/File Photo(REUTERS)
Adhanom Ghebreyesus also called on vaccine producers to prioritise Covax, the programme set up last year to equitably distribute vaccines to every corner of the planet. REUTERS/File Photo(REUTERS)
Published on Aug 05, 2021 05:30 AM IST
Copy Link
Agencies | , Geneva

Watch China's reaction to WHO's plan for audit of labs to find Covid origin

Chinese officials called WHO's plan of lab audit 'surprising' (Reuters)
Chinese officials called WHO's plan of lab audit 'surprising' (Reuters)
Published on Jul 22, 2021 05:45 PM IST
Copy Link

WHO head: Covid-19 has not defeated Tokyo Olympics

The number of Games-linked Covid-19 cases in Japan this month was 79 on Wednesday, with more international athletes testing positive at home and unable to travel.
An Uber Eats delivery person carries items near the Japan National Stadium, where opening ceremony and other events are planned for postponed Tokyo 2020 Olympics(AP)
An Uber Eats delivery person carries items near the Japan National Stadium, where opening ceremony and other events are planned for postponed Tokyo 2020 Olympics(AP)
Published on Jul 21, 2021 10:08 AM IST
Copy Link
PTI |

‘Will look into WHO proposal’: China on next phase of coronavirus origin probe

  • WHO chief Tedros Adhanom Ghebreyesus urged China to cooperate in the second phase of investigation into the origins of the coronavirus
WHO chief asked China to be “transparent, open and cooperate” as the lack of raw data, especially from the early days of the outbreak, is hindering the probe into virus origin
WHO chief asked China to be “transparent, open and cooperate” as the lack of raw data, especially from the early days of the outbreak, is hindering the probe into virus origin
Published on Jul 16, 2021 04:28 PM IST
Copy Link
By hindustantimes.com | Written by Ayshee Bhaduri | Edited by Avik Roy, Hindustan Times, New Delhi

WHO: Focus on Covid jabs for all first, boosters later

  • WHO director-general Tedros Ghebreyesus said deaths were again rising due to the pandemic and the Delta variant was becoming dominant.
A medical worker administers a shot of Russia's Sputnik V coronavirus vaccine at a vaccination center in Gostinny Dvor, a huge exhibition place in Moscow, Russia.(AP)
A medical worker administers a shot of Russia's Sputnik V coronavirus vaccine at a vaccination center in Gostinny Dvor, a huge exhibition place in Moscow, Russia.(AP)
Published on Jul 13, 2021 03:50 AM IST
Copy Link
Agencies | , Geneva, London

Covaxin's emergency use listing: All papers sent to WHO, says Bharat Biotech

Bharat Biotech also attended a pre-submission meeting scheduled with representatives of WHO on June 23.
A health worker prepares a dose of the Bharat Biotech Ltd. Covaxin vaccine at a Covid-19 vaccination center set up at the Delhi Municipal Corp.(Sumit Dayal / Bloomberg)
A health worker prepares a dose of the Bharat Biotech Ltd. Covaxin vaccine at a Covid-19 vaccination center set up at the Delhi Municipal Corp.(Sumit Dayal / Bloomberg)
Updated on Jul 13, 2021 01:55 AM IST
Copy Link
By Rhythma Kaul, New Delhi

WHO chief scientist warns coronavirus pandemic is not over. Lists main reasons

WHO has been urging nations to exercise abundant caution while relaxing Covid-19 preventative measures once cases start to decline
Soumya Swaminathan said that the delta variant is behind an increase in the number of cases being reported in five out of six WHO regions,(Photo by Raj K Raj/ Hindustan Times)
Soumya Swaminathan said that the delta variant is behind an increase in the number of cases being reported in five out of six WHO regions,(Photo by Raj K Raj/ Hindustan Times)
Published on Jul 10, 2021 03:24 PM IST
Copy Link
By hindustantimes.com | Written by Ayshee Bhaduri | Edited by Poulomi Ghosh, Hindustan Times, New Delhi

Covid 3rd wave might be a ‘ripple’: IIT scientists project 3 scenarios

  • One of the scenarios assume that without the presence of any further mutant of Covid-19, people’s lives can go back to normal by August
The team of IIT Kanpur scientists projected that if there is a presence of an immunity escape mutant, all the three scenarios will be nullified.(PTI)
The team of IIT Kanpur scientists projected that if there is a presence of an immunity escape mutant, all the three scenarios will be nullified.(PTI)
Updated on Jul 03, 2021 08:13 PM IST
Copy Link
By hindustantimes.com | Written by Sharangee Dutta | Edited by Poulomi Ghosh

Germany suggests mix and match of Covid vaccines for better immune response

  • The country recommended that people take Pfizer or Moderna as their second jab against Covid-19 four weeks after being administered with AstraZeneca’s shot
A study by Oxford University recently discovered that mixing Covid vaccines generates robust immune responses against the virus.(Reuters)
A study by Oxford University recently discovered that mixing Covid vaccines generates robust immune responses against the virus.(Reuters)
Published on Jul 03, 2021 03:54 PM IST
Copy Link
By hindustantimes.com | Written by Sharangee Dutta | Edited by Poulomi Ghosh

'Not much data to suggest Delta Plus can cause more deaths': AIIMS director

  • Talking about mixing of Covid-19 vaccine doses, Dr Randeep Guleria said that more data is needed before it can be said that the policy should be tried
Dr Randeep Guleria, director of the All India Institute of Medical Sciences (AIIMS).(PTI photo)
Dr Randeep Guleria, director of the All India Institute of Medical Sciences (AIIMS).(PTI photo)
Published on Jul 01, 2021 12:21 PM IST
Copy Link
By hindustantimes.com | Written by Sharangee Dutta | Edited by Amit Chaturvedi

Sputnik V showed 97.8% efficacy in UAE; no adverse cases seen, says RDIF

  • Sputnik V is “one of the best Covid vaccines in the world” and its inoculation helps in creating a durable immunity and also to return to a normal life, RDIF CEO Kirill Dmitriev said in a statement
The Drug Controllers General of India (DCGI) approved Sputnik V for emergency use in India besides Covishield and Covaxin.(REUTERS)
The Drug Controllers General of India (DCGI) approved Sputnik V for emergency use in India besides Covishield and Covaxin.(REUTERS)
Published on Jun 29, 2021 03:54 PM IST
Copy Link
By hindustantimes.com | Written by Sharangee Dutta | Edited by Avik Roy

Students in a fix: Mamata seeks PM’s intervention for WHO’s approval of Covaxin

  • She pointed out that several students, aspiring to go overseas, have got themselves vaccinated with Covaxin doses, and their career is at stake
West Bengal CM Mamata Banerjee. (PTI Photo)
West Bengal CM Mamata Banerjee. (PTI Photo)
Published on Jun 24, 2021 07:52 PM IST
Copy Link
By hindustantimes.com | Written by Sharangee Dutta | Edited by Poulomi Ghosh

Covid-19: Vaccinated travellers will be able to enter Egypt without PCR test

Travellers entering Egypt must present QR-coded certificates claiming that they have received their full doses of one of the six Covid-19 vaccines approved by Egypt and the WHO at least two weeks before their arrival.
Covid-19: Vaccinated travellers will be able to enter Egypt without PCR test(Photo by Simon Berger on Unsplash)
Covid-19: Vaccinated travellers will be able to enter Egypt without PCR test(Photo by Simon Berger on Unsplash)
Updated on Jun 24, 2021 04:11 PM IST
Copy Link
Reuters |

WHO ‘identifies concerns’ at Sputnik V vaccine manufacturing plant in Moscow

  • WHO inspectors also identified issues with traceability and identification of new batches of the Sputnik V vaccine
The Sputnik V vaccine, which is being manufactured by the Gamaleya Institute and the Russian Direct Investment Fund. REUTERS/Eduard Korniyenko(REUTERS)
The Sputnik V vaccine, which is being manufactured by the Gamaleya Institute and the Russian Direct Investment Fund. REUTERS/Eduard Korniyenko(REUTERS)
Published on Jun 23, 2021 10:39 PM IST
Copy Link
By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi

Bharat Biotech may attend WHO pre-submission meeting on Covaxin

  • In a major boost to Bharat Biotech, the WHO on June 18 accepted its Expression of Interest (EoI) for Covaxin and scheduled a pre-submission meeting for Wednesday.
Bharat Biotech said that it expects approval for its Covid vaccine from the health organisation for emergency use listing during July to September.(Sanchit Khanna / HT PHOTO)
Bharat Biotech said that it expects approval for its Covid vaccine from the health organisation for emergency use listing during July to September.(Sanchit Khanna / HT PHOTO)
Updated on Jun 23, 2021 09:35 AM IST
Copy Link
By hindustantimes.com | Written by Deepali Sharma | Edited by Amit Chaturvedi, Hindustan Times, New Delhi

One vaccine dose not enough against Delta variant? WHO alert amid 3rd wave worry

Dr Maria Van Kerkhove said that 2 vaccine doses provide full-level protection (Agencies)
Dr Maria Van Kerkhove said that 2 vaccine doses provide full-level protection (Agencies)
Published on Jun 22, 2021 10:49 AM IST
Copy Link

Possible 3rd wave of Covid unlikely to affect children, reveals WHO-AIIMS survey

  • The SARS-CoV-2 seropositivity rate among children was high in comparison to the adults in the survey that was conducted in five selected states with a total sample size of 10,000 by WHO-AIIMS.
Probably, these levels of seroprevalence may be protective against the third wave of Covid-19. (Representational photo)
Probably, these levels of seroprevalence may be protective against the third wave of Covid-19. (Representational photo)
Published on Jun 17, 2021 08:10 PM IST
Copy Link
By hindustantimes.com | Written by Deepali Sharma | Edited by Poulomi Ghosh, Hindustan Times, New Delhi
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Wednesday, October 20, 2021